TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.
about
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAnti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination modelMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesMatrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.A Kinetic-Model-Based Approach to Identify Malfunctioning Components in Signal Transduction Pathways from Artificial Clinical DataRole of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.Gammadelta T cells in EAE: early trafficking events and cytokine requirements.MK2 and Fas receptor contribute to the severity of CNS demyelination.Multiple sclerosis susceptibility alleles in African Americans.Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signalingSphingolipids in multiple sclerosis.IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disabilityAutophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.Inflammation in the nervous system: the human perspective.TNF ligands and receptors--a matter of life and death.Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors.Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursMultiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.Cytokines: powerful regulators of glial cell activation.Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis.Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptorConstitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation.The role of mTOR signaling pathway in spinal cord injury.IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.HMGB1 protein does not mediate the inflammatory response in spontaneous spinal cord regeneration: a hint for CNS regeneration.Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitisEfficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present.Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expressionThe regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review.How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.Cytokines: Names and Numbers You Should Care About.Neuroinflammation: the devil is in the details.Lipopolysaccharide Preconditioning Induces an Anti-inflammatory Phenotype in BV2 Microglia.Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation.IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.
P2860
Q24293476-BB42DF24-80E8-427E-9987-DCB25EA95A12Q24804031-02EA76CD-7F47-495A-8735-C4F6DFC55718Q27011014-B1A5A3A5-5707-4B40-92A5-70DB504135F9Q30486651-8642F579-D1A7-4F9E-A37E-9EC29A3A7843Q31033599-EEE9B8E5-32FA-496C-9119-B207E17659F9Q33352461-C6CC3798-7681-4CA6-AA05-7357F70B4D15Q33696788-6F2543F5-9CCB-454D-9741-7858B2DC72D2Q33725068-BC1AB0A3-6AD0-4E5F-9DEB-C386B6E040E9Q33806619-6676FE3E-19FE-4A4E-85D2-A4EEC7E753A6Q33892035-B7BB21B6-72C6-4D2D-A6E8-4B2787012471Q34203214-1A9B2772-1D59-4FFC-BF71-3A39BADD434CQ34329492-ACC4F29D-9E56-4A74-9C95-F147C880E70FQ34359503-4ADE4926-DCB4-4FD0-A891-CE40C5CA5C68Q34373132-55084664-0FD3-4CF9-B8C1-54848B73FA11Q34398679-8A3BBF3B-424B-42FB-A0B8-052EAC4369D4Q34542205-DC6E84DD-A46F-411B-849B-E5715D192FBFQ34677050-4AF21EBB-951D-4639-BFC4-8CCCCC65EE7FQ34744875-63EC9AE5-626D-446F-8719-725D8E03C1D3Q34956279-319B5119-68AC-4C5F-872E-C1B9B0184549Q35064076-C371604C-03A8-41AD-8FBB-20C17BD6CDEAQ35201289-C99FBCE6-6503-4E30-B1E5-1D009444B307Q35606563-C08E90C2-4A44-43D3-91A7-F27D81EBC92EQ35679191-7F1841BB-18AE-4B62-B179-F064E76650D7Q35723152-778894DB-2131-4B62-916F-0DF170042D87Q35742153-6C63D1CA-3EFB-453B-9E39-BB85AEAE3FD7Q36304099-585CA907-0BE6-42FB-BE1C-E5B4EB3869E0Q36742236-1A2E2E0F-A354-4A42-A71B-09C75AD9A465Q36947789-EC7E5246-BD85-4322-99E5-807E81B1BF4EQ36950333-6653CA5E-4DD7-4516-BC50-2A909D214BD0Q36989834-989761B4-829C-4E3D-971F-B219AC448ADAQ36990484-4D0EDDCE-CDD2-4A02-B314-62D2B08039B9Q37181345-26165EE7-DD62-4DFC-8D56-9D3AEE5DA195Q37284827-5F5E83D2-D66C-4E37-9271-5D45FFC51FBCQ37820180-2F5B6E51-851D-40FC-8012-C1B603CA512EQ38120199-DF5674A5-5230-413C-9491-7B95159CEBACQ38459083-66FF0CD4-4872-48F8-85B3-421C26F3F9A3Q38779873-1FF889CF-C086-4A2A-8C8B-5C3A1DA4882AQ38780545-52BE2944-CDD8-46F4-BD23-25E32D0B2DF1Q38885379-A64181CB-CE09-4881-9B5B-42EB6846E381Q41480082-323CEBCA-0019-4B75-A72B-CD5E44C1508F
P2860
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@ast
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@en
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@nl
type
label
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@ast
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@en
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@nl
prefLabel
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@ast
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@en
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@nl
P2093
P356
P1433
P1476
TNFR1 signalling is critical f ...... g immune-mediated CNS disease.
@en
P2093
P304
P356
10.1093/BRAIN/123.10.2005
P407
P478
123 ( Pt 10)
P577
2000-10-01T00:00:00Z